Abstract
Authors studied the effect of sterigmatocystin from infected corn (STC), purified sterigmatocystin (PSTC), and aflatoxin B1 from infected corn (AFB1) on lipid peroxidation and glutathione redox parameters, including the expression of their encoding genes in a sub-chronic (14 days) trial. A total of 144 three-week-old cockerels was divided into four experimental groups (n = 36 in each). Control feed was contaminated with STC or PSTC (1590 µg STC/kg or 1570.5 µg STC/kg feed), or with AFB1 (149.1 µg AFB1/kg feed). Six birds from each group were sampled at day 1, 2, 3, 7 and 14 of mycotoxin exposure. As parameters of lipid peroxidation, conjugated dienes (CD) and trienes (CT) were measured in the liver, while malondialdehyde (MDA) concentration was determined in blood plasma, red blood cell hemolysate and liver. Reduced glutathione (GSH) concentration and glutathione peroxidase (GPx) activity were determined in the same samples, and expression of glutathione peroxidase 4 (GPX4), glutathione synthetase (GSS) and glutathione reductase (GSR) genes was measured by RT-PCR in the liver. STC, PSTC or AFB1 caused a slight, but not significant, increase in CD and CT levels; however, in the case of MDA, no increase was found in the liver. Glutathione redox system was activated in the liver by AFB1, but less markedly by STC/PSTC. PSTC and AFB1 resulted in a higher expression of GPX4, while GSS expression was down-regulated by AFB1 on day 1, but up-regulated by STC on day 2 and by both mycotoxins on day 7. However, on day 14, GSS expression was down-regulated by PSTC. Expression of GSR was low on day 1 in AFB1 and PSTC groups, but later it was up-regulated by AFB1. The observed changes regarding gene expression strengthen the hypothesis that the mild oxidative stress, caused by the applied STC doses, activates the glutathione redox system of broiler chickens.
Keywords: sterigmatocystin, broiler chicken, antioxidant defense system, glutathione peroxidase, gene expression
1. Introduction
Mycotoxins are secondary metabolites of filamentous fungi, and are toxic to animals and humans. Fungi of Aspergillus genus produce several mycotoxins. Aflatoxins—which have more than ten types, the most toxic being AFB1—are mainly produced by Aspergillus flavus and Aspergillus parasiticus. Sterigmatocystin (STC), which has a molecular structure similar to aflatoxins, and acts as an intermediate in the biosynthetic pathway of aflatoxins [1], is mostly produced by Aspergillus nidulans and Aspergillus versicolor [2]. The presence of STC has been detected in a wide range of crops (e.g., corn, grains, soybean, green coffee bean, nuts), spices, in brewery and dairy products (cheeses), too [3].
Two main target organs of the STC-toxicity are kidneys and liver [4]. The pathological symptoms after STC-exposure are hepatocellular necrosis and hemorrhages in the liver and hyaline degeneration, hemorrhages and tubular necrosis in the kidneys.
STC has also immunomodulatory activity [5,6,7], and mutagenic effect [8,9] has been detected too, in in vivo and in vitro studies. Through induction of chromosomal damages and sister-chromatide exchange [10,11], it leads to cytotoxicity [12,13], inhibition of cell-cycle [14,15] and mitosis [16] as demonstrated in vitro and in vivo.
Metabolic activation of STC is similar to that of AFB1—both are metabolized by cytochrome P450 3A4 to a reactive epoxide at the furofuran ring [17]. In the target cells, this active epoxide forms 1,2-dihydro-2-(N7-guanyl)-1-hydroxy-STC adducts with the nucleic acids [18,19,20].
The International Agency for Research on Cancer (IARC) classified STC as a 2B carcinogen, which means it is possibly carcinogenic to humans, but a definitive link between human exposure and incidence of cancer has not been proven [21].
Despite the risks, there are still neither regulations nor recommendations for the maximum limits for STC in food or feed, though European Food Safety Authority (EFSA) delivered a scientific opinion about the risk of STC contamination [22].
However, the molecular structures of STC and AFB1 are quite similar (both of them are furanocoumarins), the acute toxicity of STC is approximately ten times lower [23].
The toxin explicates its effect through induction of reactive oxygen species (ROS) production during the formation of DNA-adducts [24], which results in oxidative stress in the organism. This may lead to lipid peroxidation, as a secondary mechanism of STC toxicity [25].
The effects of STC on avian species are not fully described—only limited data are available in the case of broiler chickens.
The purpose of present study was to investigate the short-term (up to three days) and longer-term (up to two weeks) effects of naturally, on ground corn substrate produced sterigmatocystin (STC), purified (99%) sterigmatocystin (PSTC) and naturally produced aflatoxin B1 (AFB1) contaminated feeds on lipid peroxidation, glutathione redox parameters and expression of genes encoding their synthesis or metabolism in some tissues of broiler chickens.
2. Materials and Methods
2.1. Animals and Experimental Design
A total of 150 one-day-old Cobb 540 cockerels was obtained from a commercial hatchery and were kept on deep litter (room temperature: 26 ± 1 °C, relative humidity: 65 ± 2%). At the age of 21 days, 144 of the chickens were randomly divided into four experimental groups (control, STC, PSTC and AFB1) consisting of 36 animals, and each of these groups was divided into two sub-groups (n = 18). The basal diet was a commercial broiler grower complete feed (Vitafort Ltd., Dabas, Hungary) free of mycotoxin sequestrates. The nutrient content (on a dry matter basis) of the diet is shown in Table 1. The nutrient content of the diet met the requirements for broiler chickens [26].
Table 1.
Metabolisable Energy (ME) | 10.69 MJ/kg |
Crude protein | 19.34% |
Crude fiber | 4.10% |
Ether extract | 2.90% |
Crude ash | 7.40% |
Calcium (Ca) | 1.02% |
Phosphorus (P) | 0.70% |
Sodium (Na) | 0.15% |
Lysine (Lys) | 0.95% |
Methionine (Met) | 0.45% |
Vitamin A | 10,050 IU/kg |
Vitamin D3 | 3015 IU/kg |
Vitamin E | 34 mg/kg |
2.2. Production of Mycotoxin Contaminated Feed
For the three treated groups, the complete feed was contaminated with grits containing STC produced by Aspergillus creber 2663, purified (99%) STC (Romer Labs, Tulln, Austria) and grits containing AFB1 produced by the high toxin producer Aspergillus flavus Zt41 [27], respectively.
To produce sterigmatocystin or aflatoxin B1 contaminated corn, the following method was used. A suspension of 108 conidia/mL was prepared in sterile distilled water from 7-day-old colonies of sterigmatocystin producer Aspergillus creber 2663 or aflatoxin producer Aspergillus flavus Zt41 grown on PDA (Potato Dextrose Agar, Merck, Darmstadt, Germany) plates. From grits, 2.5 kg portions were transferred into autoclavable plastic bags, 200 mL of distilled water was added, then the bags were autoclaved at 121 °C for 15 min. The grits were left at room temperature to cool. The contents of each bag were transferred to sterile plastic buckets of 10 L (disinfected with UV light and 70% ethanol), and they were each inoculated with 60 mL of Aspergillus creber 2663 or Aspergillus flavus Zt41 conidium suspension. The inoculum was thoroughly mixed in, and the buckets were covered with sterile canvas material and stored at 26 °C for three weeks. After the incubation period, the samples were sterilized in an autoclave and were dried at 80 °C. The mycotoxin concentrations of the contaminated corn samples were determined by HPLC analytic method: STC concentration was 7.599 mg/kg, AFB1 concentration was 4.785 mg/kg. For reaching the targeted mycotoxin contamination in the final feed, toxin containing grits were diluted with toxin-free corn.
In the case of purified sterigmatocystin-contaminated diet, sterigmatocystin was dissolved in absolute ethanol and then sprayed and mixed into the feed.
For setting the final concentrations of the sterigmatocystin contaminated diets, a ten-time correction factor was used, as the proposed toxicity of STC is lower than that of AFB1.
In control diet, the concentrations of STC and AFB1 were below the detection limit, while the experimentally contaminated diets contained mycotoxins as follows: STC—1590 µg STC/kg feed; PSTC—1570.5 µg STC/kg feed; AFB1—149.1 µg AFB1/kg feed.
2.3. Quantification of STC and AFB1 by HPLC
From the sterigmatocystin or AFB1 enriched corn grits and from the control, STC or AFB1 contaminated diets, 10 g was transferred into Stomacher bags, and 30 mL methanol was added. The samples were homogenized for 45 s in a Pulsifier instrument (Microgen Bioproducts Ltd., Camberley, UK). The bags were left standing for 24 h in the dark, and then homogenized again for 45 s for thorough extraction. The liquid part of each sample was transferred to 50 mL plastic Falcon tube and centrifuged at 20 °C, 3000 rpm, for 10 min.
For the AFB1 measurement, 1 mL of each extract was evaporated and resuspended in 0.4 mL hexane, which was followed by the addition of 0.1 mL trifluoroacetic acid (TFA) and derivatized at 60 °C for 15 min. Then 0.4 mL of water:acetonitril (9:1) was added. After mixing, the lower phase was collected, and 3 µL was applied onto a Prodigy C18 150 × 4.6 mm 5 µm column (Phenomenex, Torrance, PA, USA) in a modular Shimadzu HPLC system equipped with an RF-20A fluorescence detector (Shimadzu Europe, Duisburg, Germany). The separation was carried out at a flow rate of 1 mL/min using isocratic elution (65:35) of water and a mixture of methanol:acetonitril (1:1, v/v%). The detector wavelengths were 350 nm and 430 nm for the excitation and emission, respectively. For the STC analysis, 5 µL of the metanolic extracts were directly applied onto a Purospher STAR Rp18e 5 µm 250 × 4 mm column (Merck, Darmstadt, Germany) using the above mentioned HPLC system connected to an SPD-10AVP UV-VIS detector (254 nm). The separation was carried out at a flow rate of 0.5 mL/min using gradient elution of water and methanol, which held at 60% for 1 min, then increased to 80% at 9 min, stayed at this rate for 16 min and finally decreased to the starting value till pressure stabilization.
2.4. Sampling and Biochemical Determinations
Mycotoxin exposure began at 21 days of age. At the start of the experiment, one randomly selected bird was sampled from each sub-group from which six birds were exterminated as absolute control, resulting 17 birds remaining in each sub-group. Later, six randomly selected birds from each experimental group were sampled on day 1, 2, 3, 7, and 14 of mycotoxin exposure. Blood samples were taken after cervical dislocation. Post mortem liver samples were collected, and for gene expression studies, a small portion was put immediately to liquid nitrogen. The whole blood samples were centrifuged (1500 rpm) for 10 min to separate blood plasma. Red blood cell hemolysate was prepared with nine-fold volume of distilled water. All samples were stored at −70 °C until analysis. For the biochemical analyses, a small amount (0.5 g) of the thawed liver samples were homogenized in nine-fold volume of isotonic saline (0.65% w/v NaCl).
To investigate the initial phase of lipid peroxidation processes, the amount of conjugated dienes (CD) and trienes (CT) in the liver were measured by the ISO 3656:2011 method [28], using trimethyl-pentane and reading the absorption at 232 nm for CD and 268 nm for CT. The terminal phase of lipid peroxidation was followed by the determination of thiobarbituric acid reactive substances (TBARS), based on their color complex formation with 2-thiobarbituric acid [29] and expressed as malondialdehyde, using 1,1,3,3 tetraethoxypropane (Fluka, Buchs, Switzerland) as standard.
Reduced glutathione (GSH) concentration was determined in blood plasma, red blood cell hemolysate and 10,000 g supernatant fraction of 1:9 homogenate of liver in isotonic saline (0.65% w/v NaCl) by the method described by Rahman et al. [30]. Glutathione-peroxidase (GPx) activity was measured in the same samples as described by Matkovics et al. [31], where the loss of GSH was measured using 5,5′-dithio-bis-2-nitrobenzoic acid (DTNB). GSH content and GPx activity were calculated to the protein content of the samples, which was determined with the biuret method [32] in blood plasma and red blood cell hemolysate, while the method of Lowry et al. [33] was applied for the 10,000 g supernatant fraction of liver homogenates.
2.5. RNA Isolation, Reverse Transcriptase and qPCR
RNA extraction was performed from 6–10 mg liver homogenates by NucleoZOL reagent (Macherey-Nagel, Düren, Germany) based on the instructions of the manufacturer. RNA extraction was followed by DNA-se treatment according to the protocol of the manufacturer (Thermo Fisher Scientific, San Jose, CA, USA) to remove any genomic DNA residues. Agarose gel electrophoresis and NanoPhotometer (Implen GmbH, Munich, Germany) measurements were performed to confirm the quantity and integrity of the RNA samples. In addition, only those samples were accepted for further investigation, which had higher ratios of absorption at 260:280 nm than 2.0. For cDNA synthesis, a standard protocol was used with RevertAID Reverse Transcriptase (Thermo Fisher Scientific, San Jose, CA, USA) and random nanomer primer from 1 µg of total RNA. The primers applied for the quantification (Table 2) of the mRNA transcriptional levels of target genes (GPX4, GSS and GSR) and endogenous control gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were designed with Primer Express 3.0.1 (Thermo Fisher Scientific, San Jose, CA, USA). Endogenous control gene (GAPDH) was chosen according to literature data, as it has no known interaction with oxidative stress and mycotoxin exposure in broiler chickens, as it was used as an internal control gene in several other studies [34,35].
Table 2.
Gene | Forward Primer 5′–3′ | Reverse Primer 5′–3′ | Accession Nr. |
---|---|---|---|
GAPDH | TGACCTGCCGTCTGGAGAAA | TGTGTATCCTAGGATGCCCTTCAG | NM_204305.1 |
GPX4 | AGTGCCATCAAGTGGAACTTCAC | TTCAAGGCAGGCCGTCAT | NM_001346448.1 |
GSS | GTACTCACTGGATGTGGGTGAAGA | CGGCTCGATCTTGTCCATCAG | XM_425692.6 |
GSR | CCACCAGAAAGGGGATCTACG | ACAGAGATGGCTTCATCTTCAGTG | XM_015276627.2 |
Real-time PCR measurements were carried out in duplexes (GAPDH and one target gene) applying MGB TaqMan probes (Thermo Fisher Scientific, San Jose, CA, USA) with pooled cDNA template. The pools were formed from equal amounts (100 ng) of cDNA per 6 chicken livers of each sampled group at each sampling point of treatment in five technical replicates. Based on the results of previous experiments, no measurable differences were found if the determination was made from pooled and not from individual samples.
The PCR reaction was performed in PCR tubes (Axygen® Strips for real-time PCR) with StepOne Plus™ real-time PCR systems (Thermo Fisher Scientific, San Jose, CA, USA). For the qPCR, Maxima Probe qPCR Master Mix (1× final concentration) reaction mixture was used (Thermo Fisher Scientific, San Jose, CA, USA). The mix contained 2.5 mM MgCl2 and 5 ng cDNA, as well as the primers and dual labelled (6-fluorescein phosphoramidite (FAM) or 2′-chloro-7′phenyl-1,4-dichloro-6-carboxy-fluorescein (VIC) fluorescent die and minor groove binder-non-fluorescent quencher (MGB-NFQ)) TaqMan probes both for target and endogenous control genes in a 12.5 µL final volume per reaction. Furthermore, no-template controls were performed for each PCR measurements.
The dual labelled probes for target and endogenous control genes are listed in Table 3.
Table 3.
Gene | MGM-NFQ Dual Labelled Probe 5′–3′ | Fluorescent Dye |
---|---|---|
GAPDH | CCAGCCAAGTATGATGAT | VIC |
GPX4 | CAGCCCAATGGAG | FAM |
GSS | AGGAGGGAACAACCTG | FAM |
GSR | CTGGCACTTCGGCTC | FAM |
The PCR profile was the following: 95 °C for 10 min for pre-amplification denaturation (PAD), and 95 °C 15 sec, 58 °C 30 sec and 72 °C 30 sec for 45 cycles. Both VIC and FAM signals were detected at the end of the extension period. Amplified products were confirmed with gel electrophoresis.
The relative expression level of GPX4, GSS, GSR and endogenous housekeeping control gene, GAPDH, was determined by StepOnePlus™ Software v2.2 (Thermo Fisher Scientific, San Jose, CA, USA) using comparative Ct method. The delta Ct values (ΔCt), delta-delta Ct (ΔΔCt) and relative quantification (RQ = 2−∆∆Ct) values were calculated according to the formula described by Livak and Schmittgen [36].
2.6. Statistical Methods
Statistical analysis of the data was carried out with GraphPad Prism 6.07 software (GraphPad Software, San Diego, CA, USA) after calculating the means and standard deviations (SD).
Normality of parameters’ distribution was tested by Kolmogorov-Smirnov test, and a Barlett test was used to confirm the homogeneity of variance. All data meeting both conditions were compared using one-way ANOVA. Significance of differences between groups was estimated using Tukey-Multiple Comparison post-hoc test (p < 0.05). Otherwise, a non-parametric Kruskal-Wallis test with pairwise comparisons was used (p < 0.05). Data are presented as mean ± standard deviation (SD).
2.7. Ethical Statement
The experiment was carried out according to the Hungarian Animal Protection Act, in compliance with the EU rules. The experimental protocol was authorized by the Department of Food Chain Safety, Land Register, Plant and Soil Protection and Forestry of the Pest County Government Office (Hungary) with a permission number PE/EA/1964-7/2017.
3. Results
The average feed consumption during the two weeks long experiment was 136.2 g/bird in the control group. In mycotoxin treated groups, slightly lower feed intake was measured than in control. In decreasing order: STC 134.0 g/bird (−1.58%); PSTC 128.0 g/bird (−6.01%); AFB1 125.7 g/bird (−7.70%). The lower feed intake resulted significantly (p < 0.05) lower body weight in the STC group as compared to control on the seventh day of mycotoxin exposure. On the same sampling day, the average body weight of the STC group was significantly (p < 0.01) lower than of the AFB1 group (data not shown).
Absolute liver weight (g) was significantly (p < 0.05) lower on the second day of mycotoxin exposure in the PSTC group as compared to the control. On the seventh day, the absolute liver weights of the STC treated chickens were significantly (p < 0.001) lower than that of the AFB1 treated birds. The calculated relative liver weight (g/100 g body weight) in the STC group was significantly (p < 0.05) lower at the last sampling (14th day) as compared to the control group (data not shown).
Amounts of conjugated dienes (CD) and trienes (CT) were measured in the liver as markers of the initial phase of lipid peroxidation, while malondialdehyde (MDA) concentration as a meta-stable terminal phase marker was determined in blood plasma, red blood cell hemolysate and liver. Both applied doses of STC/PSTC and AFB1 revealed pro-oxidant effect, and caused a marked, but not significant, increase in CT and CD, but not in MDA levels in the liver (Table 4).
Table 4.
Conjugated Dienes (OD 232 nm) | ||||
Samplings | Control | STC | PSTC | AFB1 |
0 h | 0.315 ± 0.027 | |||
Day 1 | 0.261 ± 0.026 | 0.279 ± 0.028 | 0.267 ± 0.041 | 0.296 ± 0.024 |
Day 2 | 0.293 ± 0.043 | 0.334 ± 0.089 | 0.323 ± 0.059 | 0.297 ± 0.039 |
Day 3 | 0.295 ± 0.041 | 0.295 ± 0.047 | 0.304 ± 0.031 | 0.326 ± 0.023 |
Day 7 | 0.313 ± 0.028 | 0.317 ± 0.036 | 0.307 ± 0.040 | 0.320 ± 0.023 |
Day 14 | 0.311 ± 0.049 | 0.290 ± 0.026 | 0.292 ± 0.029 | 0.305 ± 0.017 |
Conjugated Trienes (OD 268 nm) | ||||
Samplings | Control | STC | PSTC | AFB1 |
0 h | 0.168 ± 0.016 | |||
Day 1 | 0.135 ± 0.012 | 0.147 ± 0.015 | 0.138 ± 0.018 | 0.153 ± 0.010 |
Day 2 | 0.145 ± 0.015 | 0.166 ± 0.033 | 0.159 ± 0.027 | 0.157 ± 0.022 |
Day 3 | 0.156 ± 0.021 | 0.151 ± 0.017 | 0.152 ± 0.012 | 0.158 ± 0.014 |
Day 7 | 0.165 ± 0.012 | 0.161 ± 0.019 | 0.157 ± 0.019 | 0.161 ± 0.012 |
Day 14 | 0.155 ± 0.007 | 0.158 ± 0.012 | 0.162 ± 0.014 | 0.164 ± 0.012 |
Thiobarbituric Acid Reactive Substances (Malondialdehyde, µmol/g Wet Weight) | ||||
Samplings | Control | STC | PSTC | AFB1 |
0 h | 19.85 ± 6.47 | |||
Day 1 | 30.45 ± 12.98 | 38.99 ± 16.25 | 26.31 ± 3.27 | 31.06 ± 4.61 |
Day 2 | 25.96 ± 8.44 | 24.49 ± 6.97 | 22.18 ± 3.91 | 24.11 ± 2.78 |
Day 3 | 17.73 ± 3.53 | 14.95 ± 6.97 | 16.19 ± 4.73 | 18.62 ± 6.99 |
Day 7 | 28.78 ± 2.68 | 25.24 ± 5.61 | 28.33 ± 6.06 | 23.20 ± 1.01 |
Day 14 | 18.53 ± 3.13 | 19.91 ± 2.78 | 20.74 ± 4.10 | 23.39 ± 3.57 |
STC—1590 µg STC/kg feed; PSTC—1570.5 µg STC/kg feed; AFB1—149.1 µg AFB1/kg feed.
The increase of free radical formation in the liver activated the glutathione redox system, as it was supported by the slightly elevated GSH concentration at both short (1st day) and long-term (14th day) AFB1 exposure compared to the control. On the second day, AFB1 caused significantly (p < 0.05) higher GSH concentration in the liver than PSTC treatment (Table 5).
Table 5.
GSH (µmol/g Protein) | ||||
Samplings | Control | STC | PSTC | AFB1 |
0 h | 3.47 ± 0.38 | |||
Day 1 | 4.84 ± 0.98 | 4.56 ± 0.79 | 5.03 ± 0.74 | 5.17 ± 1.44 |
Day 2 | 4.49 ab ± 0.73 | 4.46 ab ± 0.55 | 3.63 a ± 0.83 | 4.79 b ± 0.41 |
Day 3 | 4.81 ± 0.79 | 3.99 ± 1.42 | 3.90 ± 1.04 | 4.66 ± 2.23 |
Day 7 | 7.41 ± 0.55 | 6.58 ± 0.41 | 7.69 ± 1.32 | 7.27 ± 0.95 |
Day 14 | 5.34 ± 0.42 | 4.97 ± 0.75 | 5.95 ± 0.66 | 6.89 ± 3.11 |
GPx (U/g Protein) | ||||
Samplings | Control | STC | PSTC | AFB1 |
0 h | 3.37 ± 0.29 | |||
Day 1 | 4.68 ± 1.00 | 4.41 ± 0.71 | 5.18 ± 0.91 | 5.46 ± 0.71 |
Day 2 | 3.97 b ± 0.46 | 3.62 ab ± 0.35 | 3.06 a ± 0.62 | 4.10 b ± 0.56 |
Day 3 | 4.48 ± 0.99 | 4.04 ± 1.32 | 3.96 ± 0.87 | 4.34 ± 1.99 |
Day 7 | 6.33 ± 0.72 | 6.16 ± 0.42 | 6.84 ± 1.32 | 6.01 ± 0.39 |
Day 14 | 5.20 ± 0.36 | 4.66 ± 0.93 | 5.58 ± 0.62 | 6.27 ± 2.73 |
a,b Different superscripts in the same rows mean significant difference at p < 0.05 level. STC—1590 µg STC/kg feed; PSTC—1570.5 µg STC/kg feed; AFB1—149.1 µg AFB1/kg feed.
GPx activity of liver showed similar changes as its co-substrate (GSH), resulting in higher values at the start (first and second day) and at the end (14th day) of AFB1 treatment compared to control. On the second day of exposure, PSTC treatment caused significantly (p < 0.05) lower GPx activity than in control and in AFB1 treated groups (Table 5).
In blood plasma, AFB1 exposure resulted significantly (p < 0.05) lower GSH concentration as compared to control at the last sampling (6.99 ± 1.28 vs. 8.74 ± 1.20 µmol/g protein). GPx activity showed similar, but not significant changes as observed in its co-substrate, GSH (data not shown).
The two-week-long mycotoxin exposure did not result in significant alterations in MDA concentration, amount (GSH) and activity (GPx) of the glutathione redox system in red blood cell hemolysates (data not shown).
The gene expression of GPX4 was significantly lower on the first day of mycotoxin exposure in AFB1 group than in the control and STC groups. Later, purified STC (day 2 and 7) and aflatoxin treatments (day 2) resulted in significantly higher expression of GPX4 gene as compared to the control. At day 2, in AFB1 group, expression of GPX4 gene was significantly higher than in control, while at days 7 and 14 the gene expression was significantly higher in AFB1 group than in the control group (Table 6).
Table 6.
Gene Expression of GPX4 | ||||
Samplings | Control | STC | PSTC | AFB1 |
0 h | 1.00 ± 0.05 | |||
Day 1 | 0.57 bc ± 0.02 | 0.63 c ± 0.03 | 0.52 ab ± 0.02 | 0.50 a ± 0.04 |
Day 2 | 0.57 a ± 0.03 | 0.59 ab ± 0.01 | 0.62 b ± 0.03 | 0.63 b ± 0.02 |
Day 3 | 0.67 a ± 0.03 | 0.62 a ± 0.04 | 0.71 a ± 0.07 | 0.60 a ± 0.02 |
Day 7 | 0.51 ab ± 0.04 | 0.48 a ± 0.03 | 0.67 c ± 0.06 | 0.59 b ± 0.04 |
Day 14 | 0.48 a ± 0.03 | 0.57 c ± 0.05 | 0.50 ab ± 0.03 | 0.55 bc ± 0.03 |
Gene Expression of GSS | ||||
Samplings | Control | STC | PSTC | AFB1 |
0 h | 1.00 ± 0.02 | |||
Day 1 | 0.55 d ± 0.04 | 0.46 c ± 0.02 | 0.38 ab ± 0.05 | 0.34 a ± 0.05 |
Day 2 | 0.45 a ± 0.05 | 0.57 b ± 0.03 | 0.52 ab ± 0.05 | 0.54 a ± 0.06 |
Day 3 | 0.66 ab ± 0.05 | 0.61 ab ± 0.08 | 0.60 a ± 0.08 | 0.70 b ± 0.05 |
Day 7 | 0.41 a ± 0.04 | 0.50 b ± 0.05 | 0.70 c ± 0.06 | 1.04 d ± 0.02 |
Day 14 | 1.03 c ± 0.06 | 0.93 b ± 0.05 | 0.74 a ± 0.09 | 0.91 b ± 0.04 |
Gene Expression of GSR | ||||
Samplings | Control | STC | PSTC | AFB1 |
0 h | 1.00 ± 0.03 | |||
Day 1 | 0.43 b ± 0.06 | 0.41 b ± 0.05 | 0.28 a ± 0.03 | 0.24 a ± 0.02 |
Day 2 | 0.36 a ± 0.05 | 0.40 ab ± 0.06 | 0.41 ab ± 0.05 | 0.46 b ± 0.04 |
Day 3 | 0.47 a ± 0.04 | 0.50 a ± 0.07 | 0.68 b ± 0.10 | 0.43 a ± 0.03 |
Day 7 | 0.42 a ± 0.03 | 0.39 a ± 0.07 | 0.55 b ± 0.07 | 0.84 c ± 0.05 |
Day 14 | 0.40 a ± 0.04 | 0.64 b ± 0.08 | 0.41 a ± 0.06 | 0.44 a ± 0.08 |
a,b Different superscripts in the same rows mean significant difference at p < 0.05 level. STC—1590 µg STC/kg feed; PSTC—1570.5 µg STC/kg feed; AFB1—149.1 µg AFB1/kg feed.
Similar to the findings in the case of GPX4 on the first day of mycotoxin exposure, gene expression of GSS was also significantly lower in AFB1 group than in the control and STC groups.
On the second day, elevated GSS gene expression was observed in the STC group compared to the control. On the seventh day, the expression of the GSS gene exceeded the control in all treated groups. A week later, the lowest GSS expression was measured in the PSTC group, which was significantly different from the others (Table 6).
The gene expression of GSR was significantly lower on the first day of mycotoxin exposure in AFB1 and in PSTC groups than in the control and STC groups. On the second and seventh day of mycotoxin exposure, aflatoxin treatment significantly increased the expression of GSR gene compared to the control group. On the third and seventh days, the expression of GSR gene in the PSTC group was significantly higher than in control, while on the 14th day, STC treatment caused significantly elevated expression (Table 6).
4. Discussion
The applied dose (149.1 µg AFB1/kg feed) of aflatoxin in the feed of broiler chickens in this two-week-long feeding trial was 7.5-times higher than the regulatory limit in the EU (Commission Regulation 574/2011). It caused some alterations in production parameters (e.g., lower feed intake), had a rapid pro-oxidant effect and caused elevations in the initial, but not in the terminal phase parameters of lipid peroxidation processes in the liver, and also in the amount and activity of the glutathione redox system. The liver is the primary site of the reduced glutathione biosynthesis [37], which tripeptide—as co-substrate of selenium-dependent glutathione peroxidases and glutathione-S-transferases—has an important role in protection against the reactive oxygen species (ROS). However, Karaman et al. [38] reported depletion of GSH concentration in the liver of broilers as the effect of aflatoxin exposure, but, in the present study, no such changes were observed—possibly due to the lower dose and shorter duration of exposure. Regarding GPx activity, the literature reported marked reduction in the case of AFB1 exposure [39], but in this trial, GPx activity did not decrease significantly in the liver, though a slight increase was observed, which was possibly caused by the lower dose and shorter duration of exposure. Thus, increasing ROS formation in the cells activated the enzymes involved in the biological antioxidant system and also their gene expression. Hepatic gene expression of antioxidant enzymes, such as superoxide dismutase (SOD), GPx and glutathione S-transferase (GST) were affected (mostly down-regulated) in chickens fed with diets containing AFB1 [34,40]. In this trial, significant down-regulation of GPX4 gene was also observed a day after the start of AFB1 exposure, but later, at day 2 and day 14, up-regulation was found, suggesting an effective activation of the glutathione redox system as a response to mild oxidative stress. In the antioxidant defense system of birds, glutathione peroxidase 4 (GPX4) is more important [41] than in the case of mammals, where GPX1 plays the major role [42], which is also supported by our findings. Glutathione synthetase (GSS) catalyses the reaction of gamma-glutamylcysteine with glycine [37] to form reduced glutathione (GSH). Gene expression encoding this enzyme, involved in the two-step synthesis of GSH, showed dual response to the AFB1 exposure. A rapid down-regulation (day 1) as an early effect of oxidative stress was followed by up-regulation (day 7), suggesting effective response, but turned again to down-regulation at the end of the trial (day 14), possibly due to effective antioxidant response, which was supported by the lack of increase in the termination phase marker of lipid peroxidation, malondialdehyde content, in the liver. Glutathione reductase (GSR) catalyses the reduction of glutathione disulphide (GSSG) to reduced glutathione (GSH), maintaining the reducing environment and the sulfhydryl pool of cells [37]. Gene expression changes of GSR as a result of AFB1 exposure was similar to GSS described earlier, a rapid down-regulation (day 1) was followed by up-regulation (at days 2 and 7), which also suggests an adequate antioxidant response to oxidative stress after an early inhibitory phase regarding gene expression.
Sterigmatocysin is carcinogenic, although its carcinogenicity is about 10–100 times less than that of AFB1 in test animals [43]. The intake of STC contaminated feeds at the applied concentration, which was ten times higher than the EU regulatory limit for aflatoxin B1, caused lower body weight and reduced absolute and relative liver weights compared to the control or aflatoxin treated broilers, which means that the dose applied has a toxic effect in chicken. The literature is very scarce in connection with the effect of STC on the biological antioxidant system of avian species. The main site of its biotransformation is the liver, in which phase I enzymes (cytochrome P450 superfamily) and phase II processes are involved. The latter uses the glutathione pool of this tissue to form GSH adduct of monooxygenated STC to increase its excretion through the bile juice. In a long-term experiment with rats, STC exposure resulted in the generation of oxygen free radicals, which caused lipid peroxidation, namely elevated MDA concentration. This result was explained by the depletion of antioxidant defense [25]. In a recent experiment with broilers, slight elevation was observed in initial phase markers of lipid peroxidation, but the termination phase marker and the amount and activity of the glutathione redox system did not increase, which can be explained by the fact that the level of oxidative stress did not reach the critical level for its significant activation. These results suggested that STC has a lower oxidative stress-inducing effect than the predicted one-tenth of AFB1. There were some differences in the effects regarding protein level by naturally occurring and purified STC, which were probably caused by some other non-identified metabolites in the naturally occurring preparation. Purified STC caused significantly lower GPx activity in the liver at day 2, which was probably caused by the lower GSH concentration at the same sampling-time, which is essential for GPx activity [44]. In gene expression levels, the purified form of STC caused up-regulation of GPX4 at days 2 and 7, and naturally occurring STC at day 14, as compared to control, which suggests activation of antioxidant gene cluster even in the case of mild oxidative stress, but it requires different periods of exposure. Regarding GSS expression, the pattern of changes was similar to AFB1 in the case of both applied forms of STC. A quick down-regulation (day 1) was followed by up-regulation (day 7), which turned again to down-regulation at the end of this trial (day 14), suggesting the response to mild oxidative stress up to day 7. In GSR expression, the two applied forms of STC resulted in dissimilar changes. At days 1 and 7, the purified form of STC caused similar down-regulation as AFB1 did, but on corn grits produced form caused the opposite effect at every sampling, possibly due to the presence of some non-identified metabolites in the naturally occurring STC.
5. Conclusions
In conclusion, the results revealed that STC caused mild oxidative stress in chicken liver, and activated the glutathione redox system, as suggested by the changes regarding the level of gene expression, which did not manifest at the protein level, as well. The results also showed that the oxidative-stress induction activity of STC is lower than one-tenth of AFB1, as predicted according to other toxicity data.
Author Contributions
K.B., J.K., M.E. and M.M. designed the study; K.B., E.Z., S.K., Z.A. and B.K. performed the experiments and analyzed the results; J.K., C.D., I.B.-V. and K.I. performed the mycotoxin production on corn grits; A.S. performed the mycotoxin analyses; K.B., E.Z., J.K., A.S., B.K. and M.M. prepared the draft manuscript; all authors contributed to the discussion of the results, edited and approved the final version.
Funding
The present study was supported by the Hungarian National Research Fund (OTKA 116631) and by the EFOP-3.6.3-VEKOP-16-2017-00008 project, co-financed by the European Union and the European Social Fund, and NVKP_16-1-2016-0009 project.
Conflicts of Interest
The authors declare no conflict of interest.
References
- 1.Sweeney M.J., Dobson A.D.W. Molecular biology of mycotoxin biosynthesis. FEMS Microbiol. Lett. 1999;175:149–163. doi: 10.1111/j.1574-6968.1999.tb13614.x. [DOI] [PubMed] [Google Scholar]
- 2.Yu J., Chang P.-K., Ehrlich K.C., Cary J.W., Bhatnagar D., Cleveland T.E., Payne G.A., Linz J.E., Woloshuk C.P., Bennet J.W. Clustered pathway genes in aflatoxin biosynthesis. Appl. Environ. Microbiol. 2004;70:1253–1262. doi: 10.1128/AEM.70.3.1253-1262.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Versilovskis A., De Saeger S. Sterigmatocystin: Occurrence in foodstuffs and analytical methods—An overview. Mol. Nutr. Food Res. 2010;54:136–147. doi: 10.1002/mnfr.200900345. [DOI] [PubMed] [Google Scholar]
- 4.Purchase I.F.H., van der Watt J.J. Acute toxicity of sterigmatocystin to rats. Food Cosmet. Toxicol. 1969;7:135–139. doi: 10.1016/S0015-6264(69)80295-6. [DOI] [PubMed] [Google Scholar]
- 5.Xing L.X., Zhang X.H., Li Y.H., Yan X., Wang J., Wang F. Effects of sterigmatocystin on HLA- I expression of human peripheral blood mononuclear cells in vitro [In Chinese with English Abstract] Wei Sheng Yan Jiu. 2005;34:454–456. [PubMed] [Google Scholar]
- 6.Liu Y., Xing X., Wang J., Xing L., Su Y., Yao Z., Yan X., Wang J., Zhang X. Sterigmatocystin alters the number of FoxP3+ regulatory T cells and plasmacytoid dendritic cells in BALB/c mice. Food Chem. Toxicol. 2012;50:1920–1926. doi: 10.1016/j.fct.2012.03.005. [DOI] [PubMed] [Google Scholar]
- 7.Zhang Y., Yao Z.G., Wang J., Xing L.X., Xia Y., Zhang X.H. Effects of sterigmatocystin on TNF-alpha, IL-6 and IL-12 expression in murine peripheral blood mononuclear cells and peritoneal macrophages in vivo. Mol. Med. Rep. 2012;5:1318–1322. doi: 10.3892/mmr.2012.788. [DOI] [PubMed] [Google Scholar]
- 8.Noda K., Umeda M., Ueno Y. Cytotoxic and mutagenic effects of sterigmatocystin on cultured Chinese hamster cells. Carcinogenesis. 1981;2:945–949. doi: 10.1093/carcin/2.10.945. [DOI] [PubMed] [Google Scholar]
- 9.Baertschi S.W., Raney K.D., Shimada T., Harris T.M., Guengerich F.P. Comparison of rates of enzymatic oxidation of aflatoxin B1, aflatoxin G1, and sterigmatocystin and activities of the epoxides in forming guanyl-N7 adducts and inducing different genetic responses. Chem. Res. Toxicol. 1989;2:114–122. doi: 10.1021/tx00008a008. [DOI] [PubMed] [Google Scholar]
- 10.Curry P.T., Reed R.N., Martino R.M., Kitchin R.M. Induction of sister-chromatid exchanges in vivo in mice by the mycotoxins sterigmatocystin and griseofulvin. Mutat. Res. 1984;137:111–115. doi: 10.1016/0165-1218(84)90099-5. [DOI] [PubMed] [Google Scholar]
- 11.Ueda N., Fujie K., Gotoh-Mimura K., Chattopadhyay S.C., Sugiyama T. Acute cytogenetic effect of sterigmatocystin on rat bone-marrow cells in vivo. Mutat. Res. 1984;139:203–206. doi: 10.1016/0165-7992(84)90129-5. [DOI] [PubMed] [Google Scholar]
- 12.Bünger J., Westphal G., Monnich A., Hinnendahl B., Hallier E., Müller M. Cytotoxicity of occupationally and environmentally relevant mycotoxins. Toxicology. 2004;202:199–211. doi: 10.1016/j.tox.2004.05.007. [DOI] [PubMed] [Google Scholar]
- 13.Zouaoui N., Mallebrera B., Berrada H., Abid-Essefi S., Bacha H., Ruiz M.J. Cytotoxic effects induced by patulin, sterigmatocystin and beauvericin on CHO-K1 cells. Food Chem. Toxicol. 2016;89:92–103. doi: 10.1016/j.fct.2016.01.010. [DOI] [PubMed] [Google Scholar]
- 14.Huang S., Wang J., Xing L., Shen H., Yan X., Wang J., Zhang X. Impairment of cell cycle progression by sterigmatocystin in human pulmonary cells in vitro. Food Chem. Toxicol. 2014;66:89–95. doi: 10.1016/j.fct.2014.01.024. [DOI] [PubMed] [Google Scholar]
- 15.Xing X., Wang J., Xing L.X., Li Y.H., Yan X., Zhang X.H. Involvement of MAPK and PI3K signalling pathways in sterigmatocystin-induced G2 phase arrest in human gastric epithelium cells. Mol. Nutr. Food Res. 2011;55:749–760. doi: 10.1002/mnfr.201000344. [DOI] [PubMed] [Google Scholar]
- 16.Engelbrecht J.C., Altenkirk B. Comparison of some biological effects of sterigmatocystin and aflatoxin analogues on primary cell cultures. J. Natl. Cancer Inst. 1972;48:1647–1655. doi: 10.1093/jnci/48.6.1647. [DOI] [PubMed] [Google Scholar]
- 17.Yamazaki H., Inui Y., Wrighton S.A., Guengerich F.P., Shimada T. Procarcinogen activation by cytochrome P450 3A4 and 3A5 expressed in Escherichia coli and by human liver microsomes. Carcinogenesis. 1995;16:2167–2170. doi: 10.1093/carcin/16.9.2167. [DOI] [PubMed] [Google Scholar]
- 18.Essigmann J.M., Barker L.J., Fowler K.W., Francisco M.A., Reinhold V.N., Wogan G.N. Sterigmatocystin-DNA interactions: Identification of a major adduct formed after metabolic activation in vitro. Proc. Natl. Acad. Sci. USA. 1979;76:179–183. doi: 10.1073/pnas.76.1.179. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Essigmann J.M., Donahue P.R., Story D.L., Wogan G.N., Brunengraber H. Use of the isolated perfused rat liver to study carcinogen-DNA adduct formation from aflatoxin B1 and sterigmatocystin. Cancer Res. 1980;40:4085–4091. [PubMed] [Google Scholar]
- 20.Terao K. Sterigmatocystin – a masked potent carcinogen mycotoxin. J. Toxicol. Toxin Rev. 1983;2:77–110. doi: 10.3109/15569548309006494. [DOI] [Google Scholar]
- 21.IARC IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs vol. 1 to 42. Supplement 7. 440 Seiten. International Agency for Research on Cancer, Lyon 1987. Preis: 65,—s.Fr. Food/Nahrung. 1989;33:462. doi: 10.1002/food.19890330516. [DOI] [PubMed] [Google Scholar]
- 22.EFSA Scientific Opinion on the risk for public and animal health related to the presence of sterigmatocystin in food and feed. EFSA J. 2013;11:3254. doi: 10.2903/j.efsa.2013.3254. [DOI] [Google Scholar]
- 23.Butler J. Acute toxicity of aflatoxin B1 in rats. Br. J. Cancer. 1964;18:756–762. doi: 10.1038/bjc.1964.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Heinonen J.T., Fisher R., Brendel K., Eaton D.L. Determination of aflatoxin B1 biotransformation and binding to hepatic macromolecules in human precision liver slices. Toxicol. Appl. Pharmacol. 1996;136:1–7. doi: 10.1006/taap.1996.0001. [DOI] [PubMed] [Google Scholar]
- 25.Sivakumar V., Thanislass J., Niranjali S., Devaraj H. Lipid peroxidation as a possible secondary mechanism of sterigmatocystin toxicity. Hum. Exp. Toxicol. 2001;20:398–403. doi: 10.1191/096032701682692955. [DOI] [PubMed] [Google Scholar]
- 26.Hungarian Feed Code . Nutrient Requirements of Farm Animals. Volume II/II. OMMI; Budapest, Hungary: 2004. (In Hungarian) [Google Scholar]
- 27.Dobolyi C.S., Sebők F., Varga J., Kocsubé S., Szigeti G., Baranyi N., Szécsi Á., Tóth B., Varga M., Kriszt B., et al. Occourrence of aflatoxin producing Aspergillus flavus isolates in maize kernel in Hungary. Acta Aliment. 2013;42:451–459. doi: 10.1556/AAlim.42.2013.3.18. [DOI] [Google Scholar]
- 28.ISO 3656:2011 International Standard Fourth Edition . Animal and Vegetable Fats and Oils—Determination of Ultraviolet Absorbance Expressed as Specific UV Extinction. International Organization for Standardization (ISO); Geneva, Switzerland: 2011. [Google Scholar]
- 29.Botsoglou N.A., Fletouris D.J., Papageorgiou G.E., Vassilopoulos V.N., Mantis A.J., Trakatellis A.G. Rapid, sensitive and specific thiobarbituric acid method for measuring lipid peroxidation in animal tissue, food and feedstuff samples. J. Agric. Food Chem. 1994;42:1931–1937. doi: 10.1021/jf00045a019. [DOI] [Google Scholar]
- 30.Rahman I., Kode A., Biswas S.K. Assay for quantitative determination of glutathione and glutathione disulphide levels using enzymatic recycling method. Nat. Protoc. 2007;1:3159–3165. doi: 10.1038/nprot.2006.378. [DOI] [PubMed] [Google Scholar]
- 31.Matkovics B., Szabó I., Szöllösi Varga I. Determination of enzyme activities in lipid peroxidation and glutathione pathways. Lab. Diagn. 1998;15:248–249. [Google Scholar]
- 32.Weichselbaum T.E. An accurate and rapid method for the determination of proteins in small amounts of blood serum and plasma. Am. J. Clin. Pathol. 1946;10:40–49. doi: 10.1093/ajcp/16.3_ts.40. [DOI] [PubMed] [Google Scholar]
- 33.Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951;193:265–275. doi: 10.1016/0003-2697(79)90222-7. [DOI] [PubMed] [Google Scholar]
- 34.Yarru L.P., Settivari R.S., Antoniou E., Ledoux D.R., Rottinghaus G. Toxicological and gene expression analysis of the impact of aflatoxin B1 on hepatic function of male broiler chicks. Poult. Sci. 2009;88:360–371. doi: 10.3382/ps.2008-00258. [DOI] [PubMed] [Google Scholar]
- 35.Salem R., El-Habashi N., Fadl S.E., Sakr O.A., Elbialy Z.I. Effect of probiotic supplement on aflatoxicosis and gene expression in the liver of broiler chicken. Environ. Toxicol. Pharmacol. 2018;60:118–127. doi: 10.1016/j.etap.2018.04.015. [DOI] [PubMed] [Google Scholar]
- 36.Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–408. doi: 10.1006/meth.2001.1262. [DOI] [PubMed] [Google Scholar]
- 37.Lu S.C. Glutathione synthesis. Biochim. Biophys. Acta. 2013;1830:3143–3153. doi: 10.1016/j.bbagen.2012.09.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Karaman M., Ozen H., Tuzcu M., Ciğremiş Y., Onder F., Ozcan K. Pathological, biochemical and haematological investigations on the protective effect of alpha-lipoic acid in experimental aflatoxin toxicosis in chicks. Br. Poult. Sci. 2010;51:132–141. doi: 10.1080/00071660903401839. [DOI] [PubMed] [Google Scholar]
- 39.Eraslan G., Akdogan M., Yarsan E., Essiz D., Sahindokuyucu F., Hismiogullari S.E., Altintas L. Effects of aflatoxin and sodium bentonite administered in feed alone or combined on lipid peroxidation in the liver and kidneys of broilers. Bull. Vet. Inst. Pulawy. 2004;48:301–304. [Google Scholar]
- 40.Gowda N.K.S., Ledoux D.R., Rottinghaus G.E., Bermudez A.J., Chen Y.C. Efficacy of turmeric, containing a known level of curcumin, and a hydrated sodium calcium aluminosilicate to ameliorate the adverse effects of aflatoxin in broiler chicks. Poult. Sci. 2008;87:1125–1130. doi: 10.3382/ps.2007-00313. [DOI] [PubMed] [Google Scholar]
- 41.Huang J.Q., Li D.L., Zhao H., Sun L.H., Xia X.J., Wang K.N., Luo X., Lei X.G. The selenium deficiency disease exudative diathesis in chicks is associated with down-regulation of seven common selenoprotein genes in liver and muscle. J. Nutr. 2011;141:1605–1610. doi: 10.3945/jn.111.145722. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Labunskyy V.M., Hatfield D.L., Gladyshev V.N. Selenoproteins: Molecular pathways and physiological roles. Physiol. Rev. 2014;94:739–777. doi: 10.1152/physrev.00039.2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Purchase I.F.H., van der Watt J.J. Carcinogenicity of sterigmatocystin. Food Cosmet. Toxicol. 1970;8:289–295. doi: 10.1016/S0015-6264(70)80004-9. [DOI] [PubMed] [Google Scholar]
- 44.Sarma B.K., Mugesh G. Thiol cofactors for selenoenzymes and their synthetic mimics. Org. Biomol. Chem. 2008;6:965–974. doi: 10.1039/b716239a. [DOI] [PubMed] [Google Scholar]